| 101574-2 | Body temperature 1 hour --at admission | OBGYN |
| 101575-9 | Delayed cord clamping Newborn (qualitative) | OBGYN |
| 101576-7 | Bacterial gyrB gene drug resistance mutation (molecular method) | ABXBACT |
| 101577-5 | Cardioversion report Heart Document | CARD.PROC |
| 101578-3 | Cardiac device monitoring report | CARD.PROC |
| 101579-1 | Heart Multisection transthoracic limited (us) | CARD.US |
| 10158-4 | History of Functional status Narrative | H&P.HX |
| 101580-9 | US Heart Transthoracic limited for congenital disease | CARD.US |
| 101581-7 | US Heart Transthoracic for congenital disease | CARD.US |
| 101582-5 | NM Gastrointestinal tract Views for protein-losing enteropathy W Tc-99m HSA IV | RAD |
| 101583-3 | ESBL (qualitative, ceftazidime to ceftazidime-clavulanate ic ratio by based on lab data in positive blood culture qualitative) | ABXBACT |
| 101584-1 | Bacterial Vaginosis Associated Bacteria-2+Atopobium vaginae+Megasphaera sp type 1 DNA in Vaginal fluid (qualitative, naa with probe detection) | MICRO |
| 101585-8 | Mycobacterium avium ss paratuberculosis DNA (Stool, naa with probe detection) | MICRO |
| 101586-6 | Cortisol (lc/ms/ms) | CHEM |
| 101587-4 | Histoplasma capsulatum+Blastomyces dermatitidis Ag panel - Serum or Plasma | PANEL.MICRO |
| 101588-2 | Histoplasma capsulatum+Blastomyces dermatitidis Ag (qualitative, immunoassay) | MICRO |
| 101589-0 | Histoplasma capsulatum+Blastomyces dermatitidis Ag (immunoassay) | MICRO |
| 10159-2 | History of Industrial exposure Narrative | H&P.HX |
| 101590-8 | VKORC1 gene allele or Tissue (Blood, molecular genetics method nominal) | MOLPATH.PHARMG |
| 101591-6 | CMS - Identification Information during assessment period | PANEL.SURVEY.CMS |
| 101592-4 | CMS - Cognitive Patterns during assessment period | PANEL.SURVEY.CMS |
| 101593-2 | CMS - Delirium during assessment period | PANEL.SURVEY.CMS |
| 101594-0 | CMS - Mood during assessment period | PANEL.SURVEY.CMS |
| 101595-7 | CMS - Functional Abilities and Goals during assessment period | PANEL.SURVEY.CMS |
| 101596-5 | CMS - Prior functioning: everyday activities during assessment period | PANEL.SURVEY.CMS |
| 101597-3 | CMS - Tub and or shower transfer - functional goal (qualitative) | SURVEY.CMS |
| 101598-1 | CMS - Functional Abilities and Goals - OBRA and or Interim | PANEL.SURVEY.CMS |
| 101599-9 | CMS - Self-Care - OBRA during assessment period | PANEL.SURVEY.CMS |
| 1016-5 | E Ab from Blood product unit (qualitative) | BLDBK |
| 10160-0 | History of Medication use Narrative | H&P.HX |
| 101600-5 | CMS - Mobility - OBRA during assessment period | PANEL.SURVEY.CMS |
| 101601-3 | CMS - Active Diagnoses during assessment period | PANEL.SURVEY.CMS |
| 101602-1 | CMS - Health Conditions during assessment period | PANEL.SURVEY.CMS |
| 101603-9 | CMS - Pain assessment interview during assessment period | PANEL.SURVEY.CMS |
| 101604-7 | CMS - Swallowing and or Nutritional Status | PANEL.SURVEY.CMS |
| 101605-4 | CMS - Nutritional approaches - at discharge during assessment period | SURVEY.CMS |
| 101606-2 | CMS - Oral and or Dental Status | PANEL.SURVEY.CMS |
| 101607-0 | CMS - Skin Conditions during assessment period | PANEL.SURVEY.CMS |
| 101608-8 | CMS - Determination of Pressure Ulcer during assessment period | SURVEY.CMS |
| 101609-6 | CMS - Number of Venous and Arterial Ulcers during assessment period | SURVEY.CMS |
| 10161-8 | History of Occupational exposure Narrative | H&P.HX |
| 101610-4 | CMS - Other Ulcers, Wounds and Skin Problems during assessment period | SURVEY.CMS |
| 101611-2 | CMS - Current number of unhealed pressure injuries at each stage during assessment period | PANEL.SURVEY.CMS |
| 101612-0 | CMS - High risk drug classes - use and indication during assessment period | PANEL.SURVEY.CMS |
| 101613-8 | CMS - Header - Special Treatments, Procedures, and Programs during assessment period | PANEL.SURVEY.CMS |
| 101614-6 | CMS - Special Treatments, Procedures, and Programs during assessment period | PANEL.SURVEY.CMS |
| 101615-3 | CMS - Header - Participation in Assessment and Goal Setting during assessment period | PANEL.SURVEY.CMS |
| 101616-1 | CMS - Participation in assessment and goal setting during assessment period | SURVEY.CMS |
| 101617-9 | CMS - Discharge Plan during assessment period | PANEL.SURVEY.CMS |
| 101618-7 | CMS - Return to Community during assessment period | PANEL.SURVEY.CMS |